Showing 8 of 8 recruiting trials for “human-infection-by-orthopoxvirus”
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
👨⚕️ Laurens Liesenborghs, MD, Institute of Tropical Medicine📍 1 site📅 Started Aug 2025View details ↗
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
RecruitingNCT06885853 ↗
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
👨⚕️ Liem Binh Luong Nguyen, Degree medical doctor, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started May 2025View details ↗
A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine
Clinical and Biological Aspects of the MONKEYPOX Disease
Enrolling by InvitationNCT04398901 ↗
Neurodevelopmental Outcomes in ZIKV-Exposed Children
👨⚕️ Sarah B Mulkey, MD, PhD, Children's National Research Institute📍 2 sites📅 Started Nov 2020View details ↗
RecruitingNCT01386424 ↗
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
👨⚕️ Matthew J Memoli, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2011View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →